PMID: 12777340Jun 5, 2003Paper

Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial

The British Journal of Psychiatry : the Journal of Mental Science
R C Oude VoshaarF G Zitman

Abstract

Benzodiazepine withdrawal programmes have never been experimentally compared with a nonintervention control condition. To evaluate the efficacy and feasibility of tapering off long-term benzodiazepine use in general practice, and to evaluate the value of additional group cognitive-behavioural therapy (CBT). A 3-month randomised, 3-month controlled trial was conducted in which 180 people attempting to discontinue long-term benzodiazepine use were assigned to tapering off plus group CBT, tapering off alone or usual care. Tapering off led to a significantly higher proportion of successful discontinuations than usual care (62% nu. 21%). Adding group CBT did not increase the success rate (58% v. 62%). Neither successful discontinuation nor intervention type affected psychological functioning. Both tapering strategies showed good feasibilityin general practice. Tapering off is a feasible and effective way of discontinuing long-term benzodiazepine use in general practice. The addition of group CBT is of limited value.

References

Apr 1, 1991·British Journal of Addiction·N JoughinJ Falkowski
May 1, 1990·Journal of Affective Disorders·P TyrerP Riley
Apr 1, 1990·Controlled Clinical Trials·W D Dupont, W D Plummer
Oct 1, 1990·Archives of General Psychiatry·K RickelsD J Greenblatt
Oct 1, 1990·Archives of General Psychiatry·E SchweizerD J Greenblatt
Oct 1, 1990·International Journal of Group Psychotherapy·C Sandahl, S Rönnberg
May 4, 1985·Lancet·P TyrerD Kingdon
Feb 1, 1986·The International Journal of the Addictions·R G NathanS Davison
May 1, 1987·British Journal of Addiction·A HiggittM Lader
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·G CrouchC Hallstrom
Jun 1, 1994·The American Journal of Psychiatry·D A SpiegelA Nuzzarello
Feb 1, 1996·Behaviour Research and Therapy·K ElsesserJ Maurer

❮ Previous
Next ❯

Citations

Oct 20, 2009·Der Nervenarzt·K MannS Weyerer
Jul 5, 2007·Pharmacy World & Science : PWS·Frans H J A VissersHarry F J M Crebolder
Apr 25, 2007·Journal of General Internal Medicine·Chaim M BellPaula A Rochon
Sep 15, 2010·International Psychogeriatrics·Maria RikalaSirpa Hartikainen
Mar 22, 2013·Family Practice·Inge A T WillemsPeter L B J Lucassen
Jun 29, 2006·PharmacoEconomics·Richard C Oude VoshaarFrans G Zitman
Dec 10, 2008·CNS Drugs·Malcolm LaderJohn Donoghue
Feb 5, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Rebecca L GouldRobert J Howard
Feb 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·R C Oude VoshaarF G Zitman
Feb 15, 2014·The British Journal of Psychiatry : the Journal of Mental Science·C VicensA Leiva
Dec 4, 2012·Tijdschrift voor gerontologie en geriatrie·R C Oude Voshaar
Jun 7, 2014·Expert Opinion on Drug Safety·Allison M PaquinJames L Rudolph
Jan 7, 2016·Current Psychiatry Reports·Malcolm Lader, Andri Kyriacou
Jul 8, 2010·Sleep Medicine Clinics·Lynda BélangerCharles Morin
Jun 2, 2009·Addictive Behaviors·Jannette M ParrJason P Connor
Dec 31, 2008·Clinical Psychology & Psychotherapy·Kieron O'ConnorDonald Bouthillier
Apr 1, 2008·Journal of Evaluation in Clinical Practice·Wilma DenneboomPeter A G M De Smet
Jun 16, 2010·Journal of Evaluation in Clinical Practice·A Niroshan SiriwardenaRoderick Ørner
Jul 1, 2011·Addiction·Malcolm Lader
Jul 5, 2015·BMC Pharmacology & Toxicology·André S PollmannDavid M Gardner
Mar 23, 2017·The New England Journal of Medicine·Michael Soyka
Apr 1, 2017·BMC Complementary and Alternative Medicine·Wing-Fai YeungLi-Xing Lao
May 26, 2012·Journal of Psychopharmacology·A R Lingford-HughesUNKNOWN British Association for Psychopharmacology, Expert Reviewers Group
Oct 16, 2009·Journal of Psychopharmacology·Andrea CiprianiJohn R Geddes
Jan 30, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Caterina VicensAlfonso Leiva
Jul 6, 2018·Journal of Palliative Medicine·Jennifer PruskowskiEva Reitschuler-Cross
Jan 11, 2019·Clinical Obstetrics and Gynecology·Jaye M ShykenAlicia Forinash
Oct 9, 2019·International Journal of Clinical Pharmacy·Marija Delaš AždajićDanijela Štimac Grbić
Jun 20, 2013·The Cochrane Database of Systematic Reviews·Cecile DenisMarc Auriacombe
May 30, 2019·Health Science Reports·Fatema-Tun-Naher SakeBandana Saini
May 9, 2008·The European Journal of General Practice·Wim GorgelsFrans Zitman
Jun 1, 2005·Irish Journal of Psychological Medicine·Bangaru Raju, David Meagher
Jul 15, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Richard C Oude VoshaarFrans G Zitman
May 7, 2011·Drug and Alcohol Review·Jannette M ParrGeoffrey Mitchell
Jun 25, 2015·The Cochrane Database of Systematic Reviews·Catherine D DarkerErica Donnelly-Swift

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.